Thailand moves to re-criminalise cannabis in blow to $1bn industry

Thailand's Ministry of Public Health has ordered cannabis use to be restricted to medical purposes only, signaling a move to re-criminalize recreational use just three years after its decriminalization. This directive, driven by concerns over social problems, places the estimated $1 billion industry, previously projected to reach $1.2 billion by 2025, into significant uncertainty. While the order requires official publication to become law, it represents a substantial policy reversal for a sector that has boomed, occurring amidst wider political instability.

Analysis

The Thai government's directive to restrict cannabis to medical use represents a significant policy reversal, creating substantial uncertainty for an industry estimated at $1 billion. This move directly threatens the previous growth projection from the Thai Chamber of Commerce, which anticipated the market could reach $1.2 billion by 2025. The government's stated rationale for the crackdown is to address social problems among youth, signaling a shift away from the liberalized framework established in 2022. While the order is not yet law pending publication in the Royal Gazette, the political context, including the withdrawal of the pro-cannabis Bhumjaithai Party from the ruling coalition, suggests a weakening of political support for the industry. This regulatory whiplash exacerbates existing challenges for a sector that has operated in a relatively unregulated environment, likely stifling investment and operations for the thousands of cannabis retailers that have emerged.

Key Decisions for Investors

• Investors with exposure to the Thai cannabis sector should immediately reassess their positions due to the high probability of re-criminalization, which would nullify the investment thesis for recreational cannabis businesses.
• Monitor political developments closely, specifically any announcements regarding the publication of the directive in the Royal Gazette, as this will be the definitive catalyst for the policy change.
• The long-term outlook for the sector is now fundamentally altered; any future investment should be evaluated solely on the potential of a much smaller, more stringently regulated medical-only market, not the previous high-growth recreational model.